Safety Notices

From time to time notices relating to the safety, efficacy and quality of human medicinal products are published by the Health Products Regulatory Authority.

The issues covered by these notices include medicinal product safety information, updated efficacy information on the appropriate usage of medicines and quality defect information.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General information provided by 3rd parties as approved by the HPRA, e.g. MIMS, Direct Healthcare Professional Letter or Product Information Update

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
31/12/2005 NSAIDs 3rd Party Publications
30/11/2005 Antidepressant Medication for Children 3rd Party Publications
31/10/2005 ADVERSE DRUG REACTION REPORTING 3rd Party Publications
30/09/2005 CARDIOVASCULAR REVIEW OF NON-SELECTIVE NON-STEROIDAL 3rd Party Publications
31/08/2005 PAROXETINE (MELOXAT/PAROSER/PAROX/PAROXETINE/PAXT/SEROXAT) 3rd Party Publications
11/07/2005 Seroxat (paroxetine hydrochloride) - Important safety information from GlaxoSmithKline as approved by the Irish Medicines Board 11.07.2005 3rd Party Publications
01/07/2005 CODEINE-CONTAINING ANALGESICS 3rd Party Publications
30/06/2005 HORMONE REPLACEMENT THERAPY AND ENDOMETRIAL CANCER 3rd Party Publications
22/06/2005 Lamictal (lamotrigine) - Important safety information from GlaxoSmithKline as approved by the Irish Medicines Board 22.06.2005 3rd Party Publications
23/05/2005 Arcoxia (etoricoxib) - Important safety information from Merck Sharp & Dohme as approved by the Irish Medicines Board 3rd Party Publications